effect of clonidine and magnesium sulfate on rhinoplasty

Phase 3

Recruiting

• Conditions: Candidates for septorhinoplasty surgery.; Other plastic surgery for unacceptable cosmetic appearance; Z41.1

• Registration Number: IRCT20170413033408N4
• Lead Sponsor: Gorgan University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 9 November 2020

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 86

Inclusion Criteria

All patients with ASA I are candidates for septorhinoplasty

Exclusion Criteria

Patients with known neuromuscular disease
History of neuropathy
Obese patients BMI> 35
History of coagulation disorders
Renewed rhinoplasty
History of calcium channel blockers
A history of drug use NSAID, antiepileptic, TCA
History of underlying diseases such as asthma, migraine
History of allergies to drugs used for induction and anesthesia management used in these patients

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
The amount of bleeding volume. Timepoint: The measure of bleeding volume will be calculated from the beginning of the surgery until the end of the surgery. Method of measurement: patient bleeding is noted by collecting the blood in the bottle of suction, which is calibrated every 10 cc, and the calculation blood volume of gas in the patient’s throat.;Hemodynamic changes. Timepoint: The patient's hemodynamic monitoring will be performed from the time of entering the operating room until the end of the operation. Method of measurement: Hemodynamic criteria (heart rate, systolic, diastolic, and mean arterial blood pressure (MABP), arterial oxygen saturation) of the patient will be measured by Saadat monitoring.